Latest filing published 05 Jun 2023 for Evolent Health, Inc., €868k.
Filing timeline
BuySaleFirst 200 filings with a declared amount
Insider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +96.6%Entry US$7.73 · Close at T+365 US$15.20
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Frank J. Williams: trading record in brief
This profile gathers the share dealings of Frank J. Williams across 2 companies, led by Advisory Board Co and Evolent Health, Inc. We count 316 filings; the first trade dates from 21 March 2006 and the latest from 1 June 2023.
In open-market terms, that means 1 purchase worth €206k on one side and 178 sales worth €96.2M on the other. On balance, insiders were net sellers of €96.0M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 11 share grants and 124 option exercises. Since January 2023: no purchases and 16 sales on the market.
On 5 June 2023 came the latest disclosure, an option exercise for €868k in Evolent Health, Inc. The latest purchase dates back some time: it was published 2,530 days ago, on 5 December 2019. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Frank J. Williams
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 90,940 shares@ US$10.271.3% of flowClass A Common StockSEC:0001628908-23-000072:1
- 9,091 shares@ US$29.270.4% of flowClass A Common StockSEC:0001628908-23-000072:2
- 9,969 shares@ US$29.750.4% of flowClass A Common StockSEC:0001628908-23-000072:3
- 41,914 shares@ US$29.261.7% of flowClass A Common StockSEC:0001628908-23-000072:4
- 49,026 shares@ US$29.742.0% of flowClass A Common StockSEC:0001628908-23-000072:5
- 19,060 shares@ US$6.872.8% of flowClass A Common StockSEC:0001628908-23-000072:0
- 110,000 shares@ US$36.295.3% of flowClass A Common StockSEC:0001628908-23-000063:1
- 110,000 shares@ US$6.8716.1% of flowClass A Common StockSEC:0001628908-23-000063:0
- 104,126 shares@ US$31.804.4% of flowClass A Common StockSEC:0001628908-23-000053:1
- 5,874 shares@ US$32.370.3% of flowClass A Common StockSEC:0001628908-23-000053:2
- 110,000 shares@ US$6.8716.1% of flowClass A Common StockSEC:0001628908-23-000053:0
- 87,901 shares@ US$34.404.1% of flowClass A Common StockSEC:0001628908-23-000045:1
- 2,455 shares@ US$35.010.1% of flowClass A Common StockSEC:0001628908-23-000045:2
- 116,311 shares@ US$34.625.5% of flowClass A Common StockSEC:0001628908-23-000045:3
- 400,000 shares0Class A Common StockSEC:0001628908-23-000045:0
- 9,060 shares@ US$34.970.4% of flowClass A Common StockSEC:0001628908-23-000031:1
- 100,940 shares@ US$6.871.0% of flowClass A Common StockSEC:0001628908-23-000031:2
- 100,940 shares@ US$34.984.9% of flowClass A Common StockSEC:0001628908-23-000031:3
- 9,060 shares@ US$3.840.8% of flowClass A Common StockSEC:0001628908-23-000031:0
- 108,500 shares@ US$32.154.7% of flowClass A Common StockSEC:0001628908-23-000007:1
- 1,500 shares@ US$32.660.1% of flowClass A Common StockSEC:0001628908-23-000007:2
- 110,000 shares@ US$3.849.1% of flowClass A Common StockSEC:0001628908-23-000007:0
- 106,708 shares@ US$27.123.9% of flowClass A Common StockSEC:0001628908-23-000002:1
- 3,292 shares@ US$28.180.1% of flowClass A Common StockSEC:0001628908-23-000002:2
- 110,000 shares@ US$3.849.2% of flowClass A Common StockSEC:0001628908-23-000002:0
25 of 307 declarations
